Common Stock, Shares, Outstanding of TITAN PHARMACEUTICALS INC from 31 Dec 2010 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
TITAN PHARMACEUTICALS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Jun 2025.
  • TITAN PHARMACEUTICALS INC Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2025 was 1,330,234, a 46% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

TITAN PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 1,330,234 +416,000 +46% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 914,234 0 0% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 914,234 +132,731 +17% 31 Dec 2024 10-Q 14 Aug 2025 2025 Q2
Q3 2024 914,234 -14,102,061 -94% 30 Sep 2024 10-Q 03 Jan 2025 2024 Q3
Q2 2024 914,234 -14,102,061 -94% 30 Jun 2024 10-Q 15 Aug 2024 2024 Q2
Q1 2024 914,234 -14,102,061 -94% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 781,503 +30,688 +4.1% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 15,016,295 +387,078 +2.6% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 15,016,295 +387,078 +2.6% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 15,016,295 +2,976,874 +25% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 750,815 -9,163,343 -92% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 14,629,217 +4,765,059 +48% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 14,629,217 +4,765,149 +48% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 12,039,421 +2,175,353 +22% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 9,914,158 +2,775,090 +39% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 9,864,158 -106,899,022 -92% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 9,864,068 -87,359,112 -90% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 9,864,068 -83,603,190 -89% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 7,139,068 +5,226,441 +273% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q3 2020 116,763,180 +99,649,180 +582% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 97,223,180 +82,961,180 +582% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 93,467,258 +36,088,464 +63% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 1,912,627 -11,097,665 -85% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 17,114,000 -22,253,744 -57% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 14,262,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 57,378,794 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 13,010,292 +9,476,334 +268% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 39,367,744 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q4 2017 3,533,958 -17,664,921 -83% 31 Dec 2017 10-K/A 02 Apr 2019 2018 FY
Q4 2016 21,198,879 +1,139,059 +5.7% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 20,059,820 +60,268 +0.3% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 19,999,552 -68,794,670 -77% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q4 2013 88,794,222 +13,578,509 +18% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q4 2012 75,215,713 +15,829,171 +27% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q4 2011 59,386,542 +138,800 +0.23% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q4 2010 59,247,742 31 Dec 2010 10-K 15 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.